The Department of Pharmacology and Medical Oncology, in collaboration with Servier India organized a CME program titled “Acute Myeloid Leukemia — Journey from Diagnosis to Targeted Pharmacotherapy” on 27th June 2025. The event focused on IDH1-mutant AML and Ivosidenib therapy. Dr. Robin Ranjan from Servier delivered a talk , followed by a panel discussion moderated by Dr.Steve Thomas with experts from leading hospitals .
